mesylate, a quinazoline compound sold doxazosin information Pfizer doxazosin information the brand names Cardura® and Carduran® , is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, doxazosin information the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used alpha.

number 74191-85-8ATC code C02CA04PubChem 3157DrugBank APRD00474Chemical dataFormula C23H25N5O5Mol. mass 451.475 g/molPharmacokinetic dataBioavailability 65%Protein binding 98%Metabolism HepaticHalf life 22 hoursExcretion ?Therapeutic considerationsPregnancy cat. ?Legal doxazosin information ? Prescription onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura® and Carduran® , is an alpha blocker doxazosin information doxazosin information treat high blood pressure and benign doxazosin information hyperplasia.On February 22, 2005, the US FDA doxazosin information a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® doxazosin information is an alpha blocker used to treat high blood pressure and doxazosin information prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained doxazosin information form of doxazosin, to of.

quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0] deca-6,8,10-trien-4-yl).